Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome wide transcriptome analysis of patient matched prostate cancer using NGS technology

ABSTRACT: Genome wide transcriptome analysis of patient matched prostate cancer using NGS technology

PROVIDER: PRJNA552058 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR9623680_1.fastq.gz	Fastqsanger.gz
	SRR9623680_2.fastq.gz	Fastqsanger.gz
	SRR9623690_1.fastq.gz	Fastqsanger.gz
	SRR9623690_2.fastq.gz	Fastqsanger.gz
	SRR9623700_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 120

Similar Datasets

Genome wide transcriptome analysis of patient matched prostate cancer using NGS technology

Project description:Purpose: The goal of present study is to compare transcript level changes between normal and tumor of same individual Methods: Total RNA was isolated, strand specific RNA seq was performed after Ribosomal RNA removal, global transcript profiles were generated by deep sequencing, in duplicate, using Illumina Hiseq. Initial quality check was performed using FASTQC, Alignment was performed using Hisat2 against human hg19 genome. Raw read count was performed using SummarizedExperiment (R package). Differential analysis was done using DEseq2 Results: This study provides insights in terms of global trancriptome changes between normal and tumor of same patient. Conclusions: This study provides in depth analysis of transcriptomoc data in patient specific manner.

2019-07-02 | GSE133626 | GEO

Preanalytic Impacts on Genomic Sequencing by NGS technology

Project description:Preanalytic Impacts on Genomic Sequencing by NGS technology

| PRJNA477669 | ENA

Proteomics of prostate cancer patient derived xenografts

Project description:A set of 17 prostate cancer patient-derived xenografts (PDX, Lin et al 2014, Cancer research) was analyzed by mass spectrometry-based proteomics to characterize the effects of castration in vivo, and the proteome differences between NEPC and prostate adenocarcinomas.

2019-09-11 | PXD009636 | Pride

Patient-derived models of prostate cancer

Project description:Patient-derived models of prostate cancer

| PRJNA1000652 | ENA

Patient-derived models of prostate cancer

Project description:Patient-derived models of prostate cancer

| PRJNA1000653 | ENA

Expression profile of localized primary prostate cancer samples and the matched normal tissues

Project description:To identify new oncogenic drivers in prostate cancer, we performed transcriptome analysis of localized primary prostate cancer samples and the matched normal tissues.

2021-05-01 | GSE114740 | GEO

Prostate Cancer and Normal Adjacent Prostate RNA-seq samples, NGS-ProToCol

Project description:The dataset "Prostate Cancer and Normal Adjacent Prostate RNA-seq samples, NGS-ProToCol" includes 41 Normal Adjacent Prostate and 51 ribo-depleted Prostate Cancer RNA-seq samples.

| EGAS00001002816 | EGA

Gene expression profiles with matched NGS in B-cell non-Hodgkin lymphoma

Project description:Gene expression profiles with matched NGS in B-cell non-Hodgkin lymphoma

| PRJNA549483 | ENA

Human Prostate Cancer epithelial-fibroblast cell signalling by CTAP-MS

Project description:A greater understanding of cell signaling events that occur within the prostate cancer tumor microenvironment (TME), for example between cancer-associated fibroblasts (CAFs) and prostate epithelial or cancer cells, may identify novel biomarkers and more effective therapeutic strategies for this disease. To address this, we used cell-type specific labelling with amino acid precursors (CTAP) to define cell type-specific phosphoproteomic changes that occur when prostate epithelial cells are co-cultured with normal patient-derived prostate fibroblasts (NPFs) versus matched CAFs.

2023-03-11 | PXD037272 | Pride

Epigenomic alterations in localized and advanced prostate cancer

Project description:Here we used Illumina NGS for high-throughput profiling of the DNA methylome in seven human benign prostate tissues, seven human primary prostate cancer and six human castration resistant prostate cancer patient samples. These data were used to profile the CpG cytosine methylation pattern at single base resolution in each sample and to determine differentially methylated cytosines and regions among samples. Enhanced Reduced Representation Bisulfite Sequencing (ERRBS, MspI,150M-bM-^@M-^S400 bp size fractions) of 20 human prostate tissues (benign prostate tissues, localized and metastatic prostate cancer)

2013-07-03 | E-GEOD-41701 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data